 Shares of Calyxt NASDAQ:CLXT were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 47.83 year over year to 0.34, which missed the estimate of 0.32.Revenue of 2,377,000 up by 1414.01 year over year, which missed the estimate of 4,060,000.Outlook Earnings guidance hasnt been issued by the company for now.Calyxt hasnt issued any revenue guidance for the time being.How To Listen To The Conference Call Date: May 07, 2020View more earnings on CLXTTime: 09:05 AM ETWebcast URL: 52-week high: 16.48Companys 52-week low was at 2.40Price action over last quarter: Up 5.02Company Overview Calyxt Inc is an agricultural biotechnology company. It mainly engages in the development of food and agricultural business. The company develops and creates specialty food ingredients, such as oils and high fiber wheat, and food crops with desirable traits such as herbicide tolerance. It develops products such as reduced trans-fat soya oil, potato, gluten reduced wheat, and lower saturated fat canola oil. It generates all of its revenue from RD; contracts related to plant gene editing.See more from Benzinga Recap: Albireo Pharma Q1 Earnings Recap: International Seaways Q1 Earnings Recap: Oaktree Specialty Lending Q2 EarningsC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 